Sinocelltech Group Limited

¥31.90As of Sun 8 Nov 2026, 12:00 UTC
SSE:688520Healthcare
Country China
PE (Fwd) •••
TSR 6Y CAGR (12.68%)
Div yield —
ROE (334.53%)
Biotechnology
Beta (5Y) 0.87
PE TTM —
TSR TTM (40.60%)
Mkt cap ¥15.00B
ROIC (16.11%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥36
11.60%
35.30%
Buy 9|0|6|2|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.65
0.70
0.68
0.70
30.40%
25.53%
10.93%
18.71%
Revenue¥B
0.942
0.992
0.997
1.006
13.04%
16.76%
11.31%
7.81%
Peers (US$2.249B)
Cap (US$)
PE
2.112B
90.48x
Capital
TTM
5Y
10Y
Leveragex
1.229
(1.246)
(0.792)
EBIT/Intx
1.371
0.480
0.469
Own earn%
(40.38)
13.97
24.08
Sh yield%
29.96
28.63
25.82
Owners
Insiders/Inst%
4.47
41.94
Short interest%
5.22
SBC / revenue%
5.92
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
25–30
$1 testx
0.0
Incr. ROIC%
9